Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Werte in diesem Artikel
BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.webcasts.com/starthere.jsp?ei=1721260&tp_key=3096fdc651&tp_special=8
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-302468741.html
SOURCE Haemonetics Corporation
Übrigens: Haemonetics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Haemonetics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Haemonetics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Haemonetics Corp.
Analysen zu Haemonetics Corp.
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2017 | Haemonetics Mkt Perform | Barrington Research | |
07.11.2016 | Haemonetics Hold | The Benchmark Company | |
11.05.2016 | Haemonetics Hold | The Benchmark Company | |
05.11.2015 | Haemonetics Hold | The Benchmark Company | |
16.08.2006 | Update Haemonetics Corp.: Hold | Stanford Research |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen